Bortezomib in Treating Patients With Mantle Cell Lymphoma
Clinical trial NCT00030875 · COMPLETED
Trial details
- NCT number
- NCT00030875
- Sponsor
- NCIC Clinical Trials Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-19
- Primary completion
- 2005-07-21
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.